Aposense receives recognition for molecular imaging platform

11/6/2008 | Genetic Engineering & Biotechnology News

Aposense has received the 2008 European Technology Innovation of the Year Award in molecular/cellular imaging for its Aposense technology platform used in targeting and imaging of apoptosis, also known as programmed cell death, in medical imaging, personalized medicine and drug-development applications. The award is given to a company that has undertaken innovative research and whose work is expected to impact future adoption, change and competitive trends in the industry.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
Springfield, OR
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA